Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of administration of rhTPO at different time in the
treatment of thrombocytopenia caused by first-line GC/GP regimen for non small cell lung
cancer (NSCLC)